关注
Christos Koutsakis
Christos Koutsakis
在 upatras.gr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Key matrix remodeling enzymes: functions and targeting in cancer
Z Piperigkou, K Kyriakopoulou, C Koutsakis, S Mastronikolis, ...
Cancers 13 (6), 1441, 2021
652021
Subependymal zone-derived oligodendroblasts respond to focal demyelination but fail to generate myelin in young and aged mice
I Kazanis, KA Evans, E Andreopoulou, C Dimitriou, C Koutsakis, ...
Stem Cell Reports 8 (3), 685-700, 2017
422017
Exosomes and the extracellular matrix: A dynamic interplay in cancer progression
A Karampoga, K Tzaferi, C Koutsakis, K Kyriakopoulou, NK Karamanos
The International Journal of Developmental Biology 66 (1-2-3), 97-102, 2021
222021
How necessary is the vasculature in the life of neural stem and progenitor cells? Evidence from evolution, development and the adult nervous system
C Koutsakis, I Kazanis
Frontiers in Cellular Neuroscience 10, 35, 2016
202016
The action of hyaluronan in functional properties, morphology and expression of matrix effectors in mammary cancer cells depends on its molecular size
AG Tavianatou, Z Piperigkou, C Koutsakis, C Barbera, R Beninatto, ...
The FEBS Journal 288 (14), 4291-4310, 2021
172021
Recreating the extracellular matrix: novel 3D cell culture platforms in cancer research
K Kyriakopoulou, C Koutsakis, Z Piperigkou, NK Karamanos
The FEBS Journal 290 (22), 5238-5247, 2023
132023
Potent antiproliferative activity of bradykinin B2 receptor selective agonist FR-190997 and analogue structures thereof: A paradox resolved?
G Rassias, S Leonardi, D Rigopoulou, E Vachlioti, K Afratis, Z Piperigkou, ...
European Journal of Medicinal Chemistry 210, 112948, 2021
102021
Sulfated hyaluronan modulates the functional properties and matrix effectors expression of breast cancer cells with different estrogen receptor status
C Koutsakis, AG Tavianatou, D Kokoretsis, G Baroutas, NK Karamanos
Biomolecules 11 (12), 1916, 2021
62021
Hyaluronan as “Agent Smith” in cancer extracellular matrix pathobiology: Regulatory roles in immune response, cancer progression and targeting
D Kokoretsis, EK Maniaki, K Kyriakopoulou, C Koutsakis, Z Piperigkou, ...
IUBMB life 74 (10), 943-954, 2022
52022
pH-Sensitive Gold Nanorods for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Delivery and DNA-Binding Studies
E Zygouri, V Bekiari, G Malis, NK Karamanos, C Koutsakis, G Psomas, ...
Molecules 28 (9), 3780, 2023
32023
New analogs of polyamine toxins from spiders and wasps: Liquid phase fragment synthesis and evaluation of antiproliferative activity
C Vassileiou, S Kalantzi, E Vachlioti, CM Athanassopoulos, C Koutsakis, ...
Molecules 27 (2), 447, 2022
32022
Isolation of neural stem and oligodendrocyte progenitor cells from the brain of live rats
F McClenahan, C Dimitriou, C Koutsakis, D Dimitrakopoulos, ...
Stem Cell Reports 16 (10), 2534-2547, 2021
32021
Key Matrix Remodeling Enzymes: Functions and Targeting in Cancer. Cancers 2021, 13, 1441
Z Piperigkou, K Kyriakopoulou, C Koutsakis, S Mastronikolis, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
12021
Targeting glypicans through EGFR and JAK/STAT signaling axes drives breast cancer progression
P Ioannou, K Tzaferi, C Koutsakis, Z Piperigkou, NK Karamanos
Proteoglycan Research 2 (1), e18, 2024
2024
Sulfated Hyaluronan: A Novel Player in Cancer Therapeutic and Bioengineering Approaches
C Koutsakis, AG Tavianatou, D Kokoretsis, NK Karamanos
Hyaluronan: Structure, Biology and Biotechnology, 205-215, 2023
2023
Studying the Effects of Glycosaminoglycans in Cell Morphological Aspect with Scanning Electron Microscopy
C Koutsakis, M Franchi, AG Tavianatou, V Masola, NK Karamanos
Proteoglycans: Methods and Protocols, 99-106, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–16